MT1G and hepatocellular carcinoma: MT1G as a critical regulator of sorafenib resistance could inhibit sorafenib-induced ferroptosis in hepatocellular carcinoma through decreased glutathione depletion and lipid peroxidation (Sun et al., 2016).